Atlas Trials

Randomized Study Using SM-030 Gel for Adults With Melasma

Clinical trial NCT06454747 · RECRUITING

Trial details

NCT number
NCT06454747
Sponsor
DermBiont, Inc.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Melasma
Start date
2024-06-27
Primary completion
2025-04-01
Enrollment
138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.